Upcoming IPOs
Shree Siddhivinayak Greentech Industries25 Nov – 27 Nov₹130.00 - ₹142.00NSE EmergeFoodlink F&B Holdings26 Nov – 30 NovTBAMainboardIntegris Medtech27 Nov – 1 DecTBAMainboardA J Packaging1 Dec – 3 DecTBANSE EmergeMonomark Engineering2 Dec – 4 DecTBAMainboardHindustan Coca ColaTBATBAMainboardShree Siddhivinayak Greentech Industries25 Nov – 27 Nov₹130.00 - ₹142.00NSE EmergeFoodlink F&B Holdings26 Nov – 30 NovTBAMainboardIntegris Medtech27 Nov – 1 DecTBAMainboardA J Packaging1 Dec – 3 DecTBANSE EmergeMonomark Engineering2 Dec – 4 DecTBAMainboardHindustan Coca ColaTBATBAMainboard
All IPOs

Nukleus Office Solutions IPO Review

BSE SMEListed

Corporate Solutions · Listed on BSE · 24 Feb 2025 - 27 Feb 2025

Jagat JoshiJagat Joshi
November 20, 2026
Issue Size
31.70 Cr
Price Band
₹234.00
Lot Size
600 Shares
Min Investment
₹1,40,400
GMP
₹0
Subscription
0x
IPO Timeline
IPO OpensDONE
24 Feb 2025
IPO ClosesDONE
27 Feb 2025
Basis of AllotmentDONE
28 Feb 2025
RefundsDONE
03 Mar 2025
Demat CreditDONE
03 Mar 2025
ListingDONE
04 Mar 2025

About Nukleus Office Solutions IPO

Nukleus Office Solutions IPO is a SME IPO. The company is going to raise ₹31.70 Crores via IPO. The issue is priced at ₹234 per equity share. The IPO is to be listed on BSE.The investors' portion for QIB is 00%, NII is 50%, and Retail is 50%.The minimum bid is 600 Shares with ₹1,40,400 amount.

Advertisement

IPO Recommendations

Consensus review from market research firms & brokerage analysts

1
analyst
0
Apply
1
May Apply
0
Neutral
0
Avoid

Nukleus Office Solutions Review

ReviewerReviewDocument / Link
I
IPO Watch
May ApplyView Review

User Reviews

Community Sentiment
Votes submitted by verified retail investors
0
votes
0
Apply
0
May Apply
0
Neutral
0
Avoid

Add Your Review

What is your recommendation for this IPO?

Loading options…

How would you rate this IPO (1 to 5)?

3
Disclaimer:

The IPO reviews, and recommendations published on this page are provided by respective authors, brokers, analysts, and contributors. These views do not represent the views of IPO Watch, its management, or its staff.

IPO Watch does not guarantee about the information or recommendations provided by third-party contributors. Use this content for informational and educational purposes only.

Investors are advised to do their own research, check offer documents, and consult a qualified financial adviser before making investment decisions.

IPO Watch reserves the right to review, modify, or remove any content that does not meet the editorial guidelines.

Advertisement

Frequently Asked Questions (FAQ)

Comments0

Join the discussion

Please sign in to leave a comment or reply.

Sorted by